Search Orphan Drug Designations and Approvals
-
| Generic Name: | eflornithine HCl |
|---|---|
| Date Designated: | 03/11/2024 |
| Orphan Designation: | Treatment of Bachmann-Bupp Syndrome |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Orbus Therapeutics, Inc. 2479 East Bayshore Road Suite 105 Palo Alto, California 94303 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







